MedTrace Logo

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

NCT06056271 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-12-10

No results posted yet for this study

Summary

Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.

Conditions

Interventions

DEVICE

AF Ablation

Percutaneous, catheter-based ablation of atrial fibrillation

Sponsors & Collaborators

  • Heart Rhythm Clinical and Research Solutions, LLC

    collaborator OTHER

  • Volta Medical

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06056271 on ClinicalTrials.gov